Diabetes medication(s)-Insulin - Page 3 of 6 Posts on Medivizor
Navigation Menu

Diabetes medication(s)-Insulin Posts on Medivizor

Is it better to reduce basal insulin rate or remove insulin pump before exercise in type 1 diabetes?

Is it better to reduce basal insulin rate or remove insulin pump before exercise in type 1 diabetes?

Posted by on Mar 12, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate if reducing basal insulin rate (BRR) 90-minutes before exercise was better at preventing hypoglycemia (dangerously low blood glucose) than suspending the insulin pump (pump suspension; PS) in type 1 diabetes (T1D). The main finding was that BRR 90-minutes before exercise improved blood glucose...

Read More

Multiple daily injections compared with using an insulin pump in pregnant women with type 1 diabetes

Multiple daily injections compared with using an insulin pump in pregnant women with type 1 diabetes

Posted by on Feb 5, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectivess of an insulin pump with multiple daily injections in patients with type 1 diabetes during pregnancy. The study found that women who used MDI had better blood sugar control and lower blood pressure. Some background Women with type 1 diabetes are able to have babies very safely, as long as their blood...

Read More

Pramlintide and insulin together improves blood sugar control in type 1 diabetes

Pramlintide and insulin together improves blood sugar control in type 1 diabetes

Posted by on Dec 30, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate the effectiveness of pramlintide (Symlin) with insulin on blood glucose control in a 24-hour period. The main finding of the study was that pramlintide improved blood glucose after meals and reduced the fluctuation in blood glucose levels in patients with type 1 diabetes (T1D). Some...

Read More

Large changes in day-to-day blood sugar levels and the risk of hypoglycemia

Large changes in day-to-day blood sugar levels and the risk of hypoglycemia

Posted by on Nov 10, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate the association between the day-to-day self-monitored blood glucose level differences and the risk of hypoglycemia in insulin-treated patients with type 1 and type 2 diabetes. The study found that bigger differences in day-to-day blood glucose levels were associated with a higher risk of hypoglycemia...

Read More

Looking for people with type 1 diabetes to try an artificial pancreas

Posted by on Sep 1, 2018 in Diabetes mellitus | 0 comments

In a nutshell This clinical trial is investigating the effects of an artificial pancreas (AP) system on brain function in older adults with type 1 diabetes (T1D). The main outcome to be measured will be change in alternate fuel uptake by the brain during hypoglycemia (dangerously low blood glucose). The details Glucose is used as fuel by the brain and...

Read More

Remember the protein: calculating meal-time insulin dosing in type 1 diabetes

Remember the protein: calculating meal-time insulin dosing in type 1 diabetes

Posted by on Jun 8, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study examined whether the meal-time insulin dose should be calculated based on the carbohydrate count or the combination of carbohydrate plus protein. The study concluded that calculating the dose based on both carbohydrate and protein may be more effective. Some background Patients with type 1 diabetes can benefit from a...

Read More

Effectiveness and safety of faster aspart

Effectiveness and safety of faster aspart

Posted by on Feb 17, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of fast-acting insulin aspart (faster aspart) with conventional insulin aspart (IAsp) in people with type 1 diabetes (T1D). It was determined that faster aspart may be better at controlling blood glucose levels, without increasing the risk of side effects. Some background Reducing...

Read More

Safety and effectiveness of insulin glargine

Safety and effectiveness of insulin glargine

Posted by on Jan 26, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effectiveness and safety of two forms of insulin glargine in people with type 2 diabetes (T2D). It determined that both forms reduced HbA1c (measures average blood glucose over the last 3 months), but the more concentrated form was less likely to cause hypoglycemia (dangerously low blood glucose). Some background...

Read More